Clinical response to growth hormone in children with intrauterine growth retardation without catch-up growth in Castilla y León (Spain)

INTRODUCTION AND OBJECTIVESGrowth hormone (rhGH) is used in children with intrauterine growth retardation without catch-up growth. The Advisory Committee of Castilla y León was implemented in 2010 to watch for consistent application of the criteria for using rhGH. The aim is to assess anthropometric...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinología, diabetes y nutrición. diabetes y nutrición., 2018-12, Vol.65 (10), p.584-591
Main Authors: Gutiérrez-Abejón, Eduardo, Campo-Ortega, Eva P, Prieto-Matos, Pablo, Bahíllo-Curieses, María P, Breñas-Villalón, María T, Martín-Sobrino, Nieves
Format: Article
Language:eng ; spa
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:INTRODUCTION AND OBJECTIVESGrowth hormone (rhGH) is used in children with intrauterine growth retardation without catch-up growth. The Advisory Committee of Castilla y León was implemented in 2010 to watch for consistent application of the criteria for using rhGH. The aim is to assess anthropometric and clinical changes in children treated with growth hormone. PATIENTS AND METHODSA retrospective, longitudinal study of patients diagnosed with intrauterine growth retardation without catch-up growth in Castilla y León since 2010 who have received treatment for at least 3 years. Changes in anthropometric, clinical, and laboratory parameters were assessed. RESULTSForty-three children with a mean age of 6.06 years (58.14%
ISSN:2530-0180
DOI:10.1016/j.endinu.2018.06.007